Pelareorep: A Game-Changer in Oncolytic Virus Therapy
In this conversation, we engage with Dr. Thomas Heineman, Chief Medical Officer of Oncolytics Biotech, to explore the innovative...
Moe Alsumidaie
Transforming Clinical Trials: Medable’s Approach to Diversity and Inclusion
In this interview, we explore clinical trial technology’s impact on diversity and inclusion. Ali Holland from Medable shares insights...
Transforming Oncology with Real World Data: Insights from COTA’s Miruna Sasu
In this conversation with Miruna Sasu, President and CEO of COTA Healthcare, we explore the transformative power of real...
DM Clinical Research Data Breach Exposes Over 1.6M Records, Raising Patient Privacy Concerns
DM Clinical Research, a Texas-based clinical trial site network, has suffered a major data breach, exposing over 1.6 million...
How AI is Minimizing Clinical Trial Protocol Amendments
In this interview, we sit down with Catherine (Cat) Hall, Head of GXP Quality at Egnyte, to discuss how...
How AstraZeneca and Mass General Brigham are Enhancing Clinical Trial Protocol Design
The SCOPE 2025 Summit showcased a groundbreaking partnership between Mass General Brigham (MGB), AstraZeneca, and Evinova, highlighting how these...
Preparing and Upskilling the Clinical Trial Workforce for AI Innovation
The 2025 SCOPE Summit’s fireside chat focused on how companies are preparing and upskilling their clinical trial workforce to...
Clinical Trial Budget Negotiation Discussion Sheds Light on Inefficiency
At the SCOPE Summit 2025 Conference, a panel discussion titled “Redesigning Site Contract and Clinical Trial Budget Negotiations to...
Miist Therapeutics: Pioneering Inhaled Therapies for Rapid Smoking Cessation and Migraine Relief
In this interview, we engage with Dalton Signor, CEO at Miist Therapeutics, to explore their innovative inhaled therapies for...
Value-Added Medicines in 2025: Industry Trends and Strategic Partnerships, A Q&A with James Burt, CEO of Pharmanovia
In this interview, we sat down with James Burt, CEO of Pharmanovia, to reflect on industry trends from 2024...